Acuamark Diagnostics, Inc.

07/03/2024

Happy 4th of July!

Acuamark is wishing everyone a safe and joyous Independence Day filled with celebration and pride. As we celebrate our nation’s freedom, it is important we reflect on the need for equity and healthcare accessibility for all.

According to a recent NPR report, 50% of U.S. military bases are situated in federally designated healthcare deserts. At Acuamark, we recognize the importance of developing early detection technologies that are cost effective and easily accessible, bridging these gaps and ensuring that our service members receive the care they deserve.

Together, let's innovate for health equity.

05/31/2024

Join Acuamark's CEO at .

On Thursday, June 6, Bernard Peperstraete will speak on the panel “Competing as a Diagnostic Company in the Current Funding Environment: New Funding Models.”

We’re looking forward to an engaging discussion on the diagnostics industry's current funding landscape and new strategies for the future.

04/09/2024

President Joe Biden has declared April 2024 as Cancer Prevention and Early Detection Month, urging citizens, government agencies, businesses, nonprofits, and other groups to raise awareness about cancer prevention, detection, and treatment. (bit.ly/3xuLKZH)

Despite significant progress, the fight against cancer continues. At Acuamark, we're developing novel technology for early cancer detection with our innovative technology. By detecting cancer-specific DNA methylation using PCR technology, we aim to revolutionize early detection, making it as accessible as in-clinic COVID tests.

Learn more about our work and stay updated: acuamarkdx.com

Cancer has touched nearly every American family. During National Cancer Prevention and Early Detection Month, we honor the enormous courage and strength of the millions of Americans facing the disease today and of the many millions of survivors, whose resilience inspires us all. Together, we will en...

03/13/2024

It’s Colorectal Cancer (CRC) Awareness Month, and Acuamark is pleased to be among the innovators bringing forward new technologies to make screening and monitoring for CRC more reliable, cost-effective and accessible to all.

Acuamark’s blood-based assays target the detection of methylation patterns indicative of cancer. Methylations are among the earliest indicators of cancer. Utilizing entirely novel, straightforward and easily integrated qPCR-based methods, our technology is designed to achieve highly accurate detection results and provide a richly nuanced readout – even in the initial stages of cancer.

That’s important because CRC is one of the most widespread – but preventable – cancers, and more than 100 million Americans are eligible to be screened. Follow our progress on our website!

acuamarkdx.com

02/29/2024

Join the American College of Gastroenterology (ACG) in recognizing "Dress in Blue Day" tomorrow, March 1, 2024, rallying the GI community to wear blue and show support for lifesaving colorectal cancer screening.

Early detection is key in the fight against colorectal cancer. At , we're dedicated to developing novel technologies for early cancer detection, aiming to unlock massive benefits for patients and society at large.

Discover resources developed by ACG experts on the College's website! Link in comments.

02/26/2024

Get ready with us for Colorectal Cancer Awareness Month in March!​

Colorectal Cancer Awareness Month was established in the year 2000 with the goal to raise awareness, focus on research, support those affected by colorectal cancer and encourage health-promoting behaviors – like getting screened.​

​At , we understand that recurrent, accurate testing and monitoring can enable cancer detection at early stages, when treatment is most effective and affordable. That's why we're developing novel technology to make it happen. Learn more about our progress and follow our news on our website.​

acuamarkdx.com​